Neurofilaments in progressive multiple sclerosis: a systematic review

ConclusionsNeurofilament light has shown consistent utility as a biomarker of neuroinflammation, future brain atrophy and immunosuppressive treatment response at agroup level. Neither neurofilament light or heavy has shown a consistent treatment response to neuroprotective disease-modifying therapies, which will require further data from successful randomised controlled trials.
Source: Journal of Neurology - Category: Neurology Source Type: research